Weight Loss by Hers offers personalized clinical programs with GLP-1 injections, medication management, and ongoing support.

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Hennepin Healthcare leaders warned the county health system that runs the Hennepin County Medical Center is in "real jeopardy ...

Midland Health’s Weigh to Success returns in 2026 with lifestyle medicine, CBT, medications and bariatric surgery to help ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two years of stopping treatment.

Obesity is a complex health issue influenced by social and economic barriers, and requires a collaborative approach between government, health care professionals, community organizations, and ...

Oral semaglutide was approved by the FDA in December 2025 as a once-daily pill (25 mg), intended to limit excess body weight ...

A simple change in how primary care clinics approach weight management is delivering big public health wins. PATHWEIGH lets patients openly request help and gives doctors the tools to focus entire ...

Weight and heart benefits were fully reversed within 2 years of stopping weight-loss medications. Patients regained about 0.9 lb monthly, returning to their starting weight in just 1.7 years. Findings ...

The Miami Beach-based practice integrates the newly approved oral GLP-1 into its physician-supervised weight management programs. MIAMI BEACH, FLORIDA / ACCESS Newswire / January 15, 2026 / BODYWELLE, ...

Compared with cessation of behavioral weight management programs, weight regain was faster after cessation of medications (by 0.3 kg/month), independent of initial weight loss. HealthDay News — ...